These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4855678

  • 1. Deanol in the treatment of levodopa-induced dyskinesias.
    Miller E.
    Neurology; 1974 Feb; 24(2):116-9. PubMed ID: 4855678
    [No Abstract] [Full Text] [Related]

  • 2. Deanol in the treatment of levodopa-induced dyskinesias.
    Klawans HL, Topel JL, Bergen D.
    Neurology; 1975 Mar; 25(3):290-3. PubMed ID: 1167639
    [Abstract] [Full Text] [Related]

  • 3. Deanol in the management of involuntary movement disorders: a review.
    Casey DE.
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):7-15. PubMed ID: 145359
    [No Abstract] [Full Text] [Related]

  • 4. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action.
    Re' O.
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1238-42. PubMed ID: 4279161
    [No Abstract] [Full Text] [Related]

  • 5. Deanol in L-dopa and tardive dyskinesias: a review.
    Osvaldo NR.
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):872-5. PubMed ID: 813952
    [No Abstract] [Full Text] [Related]

  • 6. Letter: Deanol in spontaneous and induced dyskinesias.
    Laterre EC, Fortemps E.
    Lancet; 1975 Jun 07; 1(7919):1301. PubMed ID: 48933
    [No Abstract] [Full Text] [Related]

  • 7. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
    Lindeboom SF, Lakke JP.
    Acta Neurol Scand; 1978 Aug 07; 58(2):134-8. PubMed ID: 360761
    [Abstract] [Full Text] [Related]

  • 8. Letter: Deanol for tardive dyskinesia.
    N Engl J Med; 1975 Apr 24; 292(17):926-7. PubMed ID: 1117921
    [No Abstract] [Full Text] [Related]

  • 9. Deanol in tardive dyskinesia.
    De Silva L, Huang CY.
    Br Med J; 1975 Aug 23; 3(5981):466. PubMed ID: 1156821
    [No Abstract] [Full Text] [Related]

  • 10. Letter: Deanol: a solution for tardive dyskinesia?
    Miller EM.
    N Engl J Med; 1974 Oct 10; 291(15):796-7. PubMed ID: 4414178
    [No Abstract] [Full Text] [Related]

  • 11. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov 10; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 12. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Letter: Deanol in tardive dyskinesia.
    Tarsy D.
    N Engl J Med; 1974 Dec 26; 291(26):1416. PubMed ID: 4427649
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Letter: Dimethylaminoethanol in tardive dyskinesia.
    Casey DE, Denney D.
    N Engl J Med; 1974 Oct 10; 291(15):797. PubMed ID: 4414187
    [No Abstract] [Full Text] [Related]

  • 17. Deanol in the treatment of tardive dyskinesia.
    Casey DE, Denny D.
    Am J Psychiatry; 1975 Aug 10; 132(8):864-7. PubMed ID: 1147074
    [Abstract] [Full Text] [Related]

  • 18. M.I.F.: effect on levodopa dyskinesias in man.
    Woods AC, Chase TN.
    Lancet; 1973 Sep 01; 2(7827):513. PubMed ID: 4125041
    [No Abstract] [Full Text] [Related]

  • 19. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL, Weiner WJ.
    J Neurol Neurosurg Psychiatry; 1974 Apr 01; 37(4):427-30. PubMed ID: 4838914
    [Abstract] [Full Text] [Related]

  • 20. Treatment of drug-induced dyskinesias.
    Villeneuve A, Böszörményi Z.
    Lancet; 1970 Feb 14; 1(7642):353-4. PubMed ID: 4189600
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.